The prospective study looked at 77 patients undergoing ALIF procedures with the device. Independent radiologists analyzed the 138 spine segment levels treated, and found a 100 percent fusion rate between 6 and 12 months, according to the release.
The Endoskeleton implant uses a proprietary acid-etched surface to support bone purchase and new bone growth.
More Articles on Supply Chain:
Medtronic to Recruit 323 Patients for Back Pain Treatment Clinical Trial
Medical Device Purchase: 3 Statistics on Physician Influence
FDA Increases Stryker Knee Device Recall to Class 1
